Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition:   Intrahepatic Cholestasis Associated With Alcoholic Liver DiseaseInterventions:   Drug: Ademetionine IV+tablet;   Drug: Ademetionine tabletSponsors:   Abbott;   Ascent;   Datamap;   ClinIntel;   CatalentActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2014 Category: Research Source Type: clinical trials

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition:   Intrahepatic Cholestasis Associated With Alcoholic Liver DiseaseInterventions:   Drug: Ademetionine IV+tablet;   Drug: Ademetionine tabletSponsors:   Abbott;   Ascent;   Datamap;   ClinIntel;   CatalentRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2014 Category: Research Source Type: clinical trials

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsor:   Lumena Pharmaceuticals, Inc.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsor:   ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsor:   Lumena Pharmaceuticals, Inc.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials